<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-viruses-12-00122">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ye</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yao</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Cheng</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection</article-title>
  <source>Front. Pharmacol.</source>
  <year>2019</year>
  <volume>10</volume>
  <fpage>1203</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2019.01203</pub-id>
  <?supplied-pmid 31680975?>
  <pub-id pub-id-type="pmid">31680975</pub-id>
 </element-citation>
</ref>
